Kidswell Bio Corporation (TYO:4584)

Kidswell Bio Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue Revenue Growth	6,589	6,589	5,082	1,569	996	1,077
Revenue Growth	29.65%	29.65%	223.90%	57.53%	-7.52%	5.41%
Gross Profit Gross Profit Growth	1,523	1,523	1,433	1,018	876	423
Operating Income Operating Income Growth	-139	-139	28	-919	-970	-1,162
Net Income Net Income Growth	-413	-413	-21	-535	-1,001	-7,316
Earnings Per Share EPS Growth	-8.46	-8.46	-0.52	-17.34	-34.77	-264.64
EPS Growth	-	-	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Investments Cash & Investments Growth	3,294	3,294	2,995	1,187	1,461	2,032
Total Debt Total Debt Growth	2,549	2,549	1,837	700	1,100	1,225
Net Cash (Debt) Net Cash Growth	745	745	1,158	487	361	807
Net Cash Growth	-35.66%	-35.66%	137.78%	34.90%	-55.27%	-59.84%
Net Cash Per Share Net Cash Per Share Growth	15.27	15.27	28.59	15.79	12.54	29.19

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Cash Flow Operating Cash Flow Growth	-1,096	-1,096	936	-1,169	-1,267	-1,325
Capital Expenditures CapEx Growth	-17	-17	-6	-	-	-1
Free Cash Flow Free Cash Flow Growth	-1,113	-1,113	930	-1,169	-1,267	-1,326
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Gross Margin	23.11%	23.11%	28.20%	64.88%	87.95%	39.28%
Operating Margin	-2.11%	-2.11%	0.55%	-58.57%	-97.39%	-107.89%
Pretax Margin	-6.10%	-6.10%	1.44%	-34.03%	-100.40%	-679.11%
Profit Margin	-6.27%	-6.27%	-0.41%	-34.10%	-100.50%	-679.29%
FCF Margin	-16.89%	-16.89%	18.30%	-74.51%	-127.21%	-123.12%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Forward PE	7.77	14.25	15.50	-	-	-
P/FCF Ratio	-	-	5.18	-	-	-
PS Ratio	1.13	1.83	0.95	9.22	14.99	13.45

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error